We are live on ! Find out more
MDLN

Medline Inc

314 hedge funds and large institutions have $28.3B invested in Medline Inc in 2026 Q1 according to their latest regulatory filings, with 153 funds opening new positions, 107 increasing their positions, 32 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

283% more first-time investments, than exits

New positions opened: 153 | Existing positions closed: 40

234% more repeat investments, than reductions

Existing positions increased: 107 | Existing positions reduced: 32

171% more call options, than puts

Call options by funds: $120M | Put options by funds: $44.3M

58% more funds holding in top 10

Funds holding in top 10: 1219 (+7)

53% more funds holding

Funds holding: 205314 (+109)

18% more capital invested

Capital invested by funds: $23.9B → $28.3B (+$4.37B)

6.01% more ownership

Funds ownership: 72.43%78.44% (+6%)

Holders
314
Holders Change
+109
Holders Change %
+53.17%
% of All Funds
3.85%
Holding in Top 10
19
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+58.33%
% of All Funds
0.23%
New
153
Increased
107
Reduced
32
Closed
40
Calls
$120M
Puts
$44.3M
Net Calls
+$75.8M
Net Calls Change
+$130M
Name Holding Trade Value Shares
Change
Change in
Stake
UBS AM
51
UBS AM
Illinois
$56.4M +$37.4M +846,573 +201%
Kayne Anderson Rudnick Investment Management
52
Kayne Anderson Rudnick Investment Management
California
$54.8M +$12.6M +284,507 +30%
Northern Trust
53
Northern Trust
Illinois
$54.1M +$33M +748,413 +160%
WP
54
Woodline Partners
California
$54M +$22.1M +500,175 +70%
William Blair & Company
55
William Blair & Company
Illinois
$51.9M +$49.3M +1,117,380 +2,325%
Two Sigma Investments
56
Two Sigma Investments
New York
$50.7M +$50M +1,132,048 +17,416%
FGP
57
Freestone Grove Partners
California
$48.5M +$25.7M +582,514 +115%
Qube Research & Technologies (QRT)
58
Qube Research & Technologies (QRT)
United Kingdom
$47M +$46.7M +1,057,071 New
IMCOOI
59
Investment Management Corp of Ontario (IMCO)
Canada
$45.1M +$44.8M +1,013,902 New
Charles Schwab
60
Charles Schwab
California
$44.1M +$9.28M +210,159 +27%
Parnassus Investments
61
Parnassus Investments
California
$44M +$43.6M +988,143 New
National Pension Service
62
National Pension Service
South Korea
$40M
Verition Fund Management
63
Verition Fund Management
Connecticut
$38.1M +$4.66M +105,570 +14%
Holocene Advisors
64
Holocene Advisors
New York
$37M +$11.2M +253,700 +44%
Federated Hermes
65
Federated Hermes
Pennsylvania
$36.5M +$34.7M +785,317 +2,244%
MC
66
Maverick Capital
Texas
$35.4M
Bank of New York Mellon
67
Bank of New York Mellon
New York
$31.4M +$29M +656,135 +1,335%
KCM
68
Khrom Capital Management
Florida
$31.3M +$31M +703,137 New
BBCM
69
Broad Bay Capital Management
New York
$30M +$29.8M +675,000 New
Marshall Wace
70
Marshall Wace
United Kingdom
$28.6M +$21.9M +496,228 +341%
LP
71
Longaeva Partners
Illinois
$28.3M +$24.1M +544,762 +604%
Balyasny Asset Management
72
Balyasny Asset Management
Illinois
$27.5M +$16.9M +382,037 +162%
Envestnet Asset Management
73
Envestnet Asset Management
Illinois
$26.9M +$12.5M +282,094 +88%
N
74
Nuveen
North Carolina
$26.3M -$42.1M -954,057 -62%
AC
75
Armistice Capital
New York
$25.1M +$22.4M +506,841 +874%

MDLN Hedge Fund Activity: Q1 2026 in Review

314 of the 8,157 institutional investors tracked by Wall St. Rank reported a position in Medline Inc (MDLN) for Q1 2026, worth a combined $28.3B — up 18% from $23.9B a quarter earlier.

Buyers outnumbered sellers: 153 funds opened new MDLN positions and 40 closed out — a net gain of 113 holders — while 107 added to existing stakes and 32 trimmed.

The largest buyer was Invesco, adding an estimated $814M. The largest seller was Carlyle Group, cutting an estimated $1.25B.

  • 314 institutional investors held Medline Inc (MDLN) as of Q1 2026, up from 205 in Q4 2025.
  • Funds reported $28.3B of Medline Inc stock for Q1 2026, up 18% quarter-over-quarter.
  • 153 funds opened new Medline Inc positions in Q1 2026 and 40 closed out, a net change of +113 holders.
  • The largest Medline Inc buyer in Q1 2026 was Invesco, an estimated $814M added.
  • The largest Medline Inc seller in Q1 2026 was Carlyle Group, an estimated $1.25B sold.

Based on aggregated 13F filings for Q1 2026.